Clinical trial
Assessment of Effective Phaco Time and Endothelial Cell Loss When Using a Novel Dual Mode Phacoemulsification System
NCT07176416 is registered in ClinicalTrials.gov with Aloha Vision Consultants as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Effective Phaco Time and Endothelial Cell Loss When Using a Novel Dual Mode Phacoemulsification System
- Lead sponsor
- Aloha Vision Consultants
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 3, 2025
- Completion date
- October 1, 2026
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.